What is the domestic price and medical insurance reimbursement price of Dacomitinib?

Dacomitinib is currently on the market in China and has been included in my country's medical insurance reimbursement items. When patients purchase dacomitinib, they can enjoy discounts from medical insurance. The specification of the original drug is 15mg*30 tablets, and the market retail price is approximately 5680 yuan. After reimbursement through medical insurance, patients only need to pay a lower fee, usually around 1,300 yuan, which greatly reduces the patient's financial burden. For specific reimbursement ratios and conditions, patients can consult the local medical insurance reimbursement department for detailed information.

The price of dacomitinib abroad is higher than that in China. For example, the original version of the drug marketed in Europe has a specification of 45mg*30 capsules and can be sold for 24,000 yuan. Compared with domestic prices, prices in foreign markets are significantly more expensive, and prices vary greatly in each region. These differences are largely influenced by local drug pricing policies, taxes and other economic factors, so patients may face higher costs for treatment if they choose to purchase overseas.

Lao generic drugs are an economical option for patients who wish to reduce the cost of treatment. The local price of dacomitinib generics produced by Laos Lucius Pharmaceutical Company is about 1,000 yuan, which is much cheaper than the original drug. Although generic drugs cost less to produce, they contain the same ingredients as the brand-name drugs and provide similar therapeutic benefits. However, when choosing generic drugs, patients still need to fully communicate with their doctors to ensure that the quality and effectiveness of the generic drugs meet their treatment needs.

Since the pricing of dacomitinib varies greatly in different countries and regions, patients need to understand the latest market information when purchasing and choose appropriate purchasing channels based on their own economic conditions. Although prices are more favorable when covered by domestic medical insurance, for some patients who are not covered by medical insurance or who need to purchase drugs across borders, it is also important to understand the prices in other regions. It is recommended that patients communicate with their doctors and pharmacists during treatment to ensure that they choose the version of the drug that best suits them.

Reference materials:https://www.pfizer.com/products/product-detail/vizimpro